Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Dyslipidemia on Metabolic Health of Adults With Overweight/Obesity (IDOM): An Observational, Retrospective Cohort Study at the San Raffaele Hospital Center for Metabolic Health

NCT07919158 is registered in ClinicalTrials.gov with Rovere Querini Patrizia as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07919158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Dyslipidemia on Metabolic Health of Adults With Overweight/Obesity (IDOM): An Observational, Retrospective Cohort Study at the San Raffaele Hospital Center for Metabolic Health
Lead sponsor
Rovere Querini Patrizia
Phase
Observational
Overall status
Active, not recruiting
Start date
October 1, 2024
Completion date
May 31, 2027
Enrollment
900 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia, obesity & overweight

Arms

As registered; 1 arm.

  • PATIENTS WITH OVERWEIGHT OR OBESITY

    * Age ≥ 18 years; overweight/obesity.
    * BMI ≥ 25 kg/m2
    * Availability of complete baseline Iipid profile (TC, LDL.-C, TG, HDL-C) No additional intrventions.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • To estimate the prevalence of dyslipidemia and assess its association with metabolic health in adults with overweight or obesity. baseline

    1a. Prevalence of dyslipidemia (≥1 lipid criterion met): TC ≥200 mg/dL; fasting TG ≥150 mg/dL; HDL \<40 mg/dL (men) or \<50 mg/dL (women); LDL exceeding risk-category-specific threshold (\>116 / \>100 / \>70 / \>55 mg/dL for low / moderate / high / very high CV risk).

    1b. Odds ratio (OR) for dyslipidemia across metabolic categories (intermediate vs. healthy; unhealthy vs. healthy).

    Metabolic health score (0-5): 1 point each for: (1) fasting glucose ≥100 mg/dL or HbA1c ≥5.7% or antidiabetic therapy; (2) SBP ≥130 or DBP ≥85 mmHg or antihypertensive therapy; (3) waist circumference ≥94 cm (men) / ≥80 cm (women); (4) hs-CRP \>0.3 mg/dL, (5) history of liver steatosis.

    Lipid parameters excluded to avoid circularity. Categories: healthy (0), intermediate (1-2), unhealthy (≥3).

Lead sponsor's other trials

Rovere Querini Patrizia, most recent start first.

Similar trials

Same condition (Dyslipidemias) and phase, most recent start first.